5-amino-1-(2,6-dichlorophenyl)-1H-pyrazole-4-carbonitrile | 792953-01-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 5-amino-1-(2,6-dichlorophenyl)-1H-pyrazole-4-carbonitrile
• 英文别名: 5-amino-1-(2,6-dichlorophenyl)pyrazole-4-carbonitrile
• CAS: 792953-01-6
• 化学式: C₁₀H₆Cl₂N₄
• 分子量: 253.09
• InChiKey: KVARRCNLKYNSJX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  67.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-amino-1-(2,6-dichlorophenyl)-1H-pyrazole-4-carbonitrile 在 亚硝酸特丁酯 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 以81%的产率得到
  参考文献：
  名称：

  Synthesis and antileishmanial activity of new 1-aryl-1H-pyrazole-4-carboximidamides derivatives

  摘要：

  针对由利什曼原虫属寄生虫引起的利什曼病的化疗，在多种治疗中仍显低效。因此，寻找新药物变得十分必要。在本研究中，我们合成了1-芳基-1H-吡唑-4-羧酰亚胺衍生物，并对其抗利什曼活性进行了体外评估，同时也考察了其细胞毒性效应。我们对系列化合物进行了构效关系（SAR）研究。化合物2显示出一种活性特征，可通过药物化学策略进一步优化。

  DOI：

  10.1590/s0103-50532011000200022
• 作为产物：
  描述：

  乙氧基亚甲基丙二腈 、 1-(2,6-二氯苯基)肼 在 sodium acetate 作用下， 以 乙醇 为溶剂， 反应 1.5h， 生成 5-amino-1-(2,6-dichlorophenyl)-1H-pyrazole-4-carbonitrile
  参考文献：
  名称：

  Effectiveness of Novel 5-(5-amino-1-aryl-1H-pyrazol-4-yl)-1H-tetrazole Derivatives Against Promastigotes and Amastigotes ofLeishmania amazonensis

  摘要：

  In this research, a series of substituted 5‐(5‐amino‐1‐aryl‐1H‐pyrazol‐4‐yl)‐1H‐tetrazoles were synthesized and evaluated for in vitro antileishmanial activity. Among the derivatives, examined compounds 3b and 3l exhibited promising activity against promastigotes and amastigotes forms of Leishmania amazonensis. The cytotoxicity of these compounds was evaluated on murine cells, giving access to the corresponding selectivity index (SI).

  DOI：

  10.1111/cbdd.12235

文献信息

• 6-Arylmethyl-substituted pyrazolopyrimidines
  申请人：Hendrix Martin

  公开号：US20070161662A1

  公开（公告）日：2007-07-12

  The invention relates to novel 6-arylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.

  这项发明涉及新型的6-芳基甲基取代的吡唑吡嘧啶化合物，其制备方法以及它们用于生产用于改善感知、集中力、学习和/或记忆的药物。
• 6-Cyclylmethyl- and 6-alkylmethyl-substituted pyrazolepyrimidines
  申请人：Hendrix Martin

  公开号：US20070105876A1

  公开（公告）日：2007-05-10

  The invention relates to novel 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines, process for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.

  这项发明涉及新颖的6-环己甲基和6-烷基甲基取代的吡唑吡咯嘧啶化合物，其制备方法以及它们用于生产用于改善感知、集中力、学习和/或记忆的药物。
• THERAPEUTIC AGENTS 414
  申请人：BENNETT Stuart Norman Lile

  公开号：US20100093757A1

  公开（公告）日：2010-04-15

  A compound of Formula (I): is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.

  化合物Formula (I)在通过葡萄糖激酶（GLK或GK）介导的疾病或医疗状况的治疗或预防中很有用，导致胰岛素分泌的葡萄糖阈值降低。
• Synthesis and antileishmanial activity of new 1-aryl-1H-pyrazole-4-carboximidamides derivatives
  作者：Maurício S. dos Santos、Adriana O Gomes、Alice M. R Bernardino、Marcos C. de Souza、Misbahul A Khan、Monique A. de Brito、Helena C Castro、Paula A Abreu、Carlos R Rodrigues、Rosa M. M. de Léo、Leonor L Leon、Marilene M Canto-Cavalheiro

  DOI：10.1590/s0103-50532011000200022

  日期：——

  Chemotherapy for leishmaniasis, diseases caused by protozoa of the genus Leishmania, remains inefficient in several treatments. So there is a need to search for new drugs. In this work, we have synthesized 1-aryl-1H-pyrazole-4-carboximidamides derivatives and evaluated antileishmanial activities in vitro, as well as cytotoxic effects. Structure-activity relationship (SAR) studies were carried out with all the compounds of the series. Compound 2 showed an activity profile that can be improved through medicinal chemistry strategies.

  针对由利什曼原虫属寄生虫引起的利什曼病的化疗，在多种治疗中仍显低效。因此，寻找新药物变得十分必要。在本研究中，我们合成了1-芳基-1H-吡唑-4-羧酰亚胺衍生物，并对其抗利什曼活性进行了体外评估，同时也考察了其细胞毒性效应。我们对系列化合物进行了构效关系（SAR）研究。化合物2显示出一种活性特征，可通过药物化学策略进一步优化。
• [EN] 1, 5-DIHYDRO-PYRAZOLO (3, 4-D) PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS PDE9A MODULATORS FOR THE TEATMENT OF CNS DISORDERS<br/>[FR] DÉRIVÉS DE 1,5-DIHYDRO-PYRAZOLO(3,4-D)PYRIMIDIN-4-ONE ET LEUR UTILISATION EN TANT QUE MODULATEURS DE PDE9A POUR LE TRAITEMENT DE TROUBLES DU SNC
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2009068617A1

  公开（公告）日：2009-06-04

  The invention relates to novel substituted pyrazolopyrimidines. Chemically, the compounds are characterised by general Formula (I): with R1 being phenyl or pyridyl, any of which is substituted with 1 to 4, preferably 1 to 3 substituents X; X independently of each other being selected from C2-C6-alky1 or Ci-C6-alkoxy, where C2-C6-alkyl and C1-C6-alkoxy are at least dihalogenated up to perhalogenated. preferably with 2 to 6 halogen substituents, and the halogen atoms being selected from the group of fluoro, chloro and bromo, preferably fluoro; R2 being phenyl or heteroaryl, where phenyl is substituted by 1 to 3 radicals and heteroaryl is optionally substituted by 1 to 3 radicals in each case independently of one another selected from the group of C1-C6-alkyI, C1-C6- alkoxy, hydroxycarbonyl, cyano, trifluoromethyl, amino, nitro, hydroxy, C1-C6- alkylamino, halogen, C6-C10-arylcarbonylamino, C1-C6-alkylcarbonylamino, C1- C6-alkylaminocarbonyl. C1-C6-alkoxycarbonyl, C6-C10-arylaminocarbonyl, heteroarylaminocarbonyl. heteroarylcarbonylamino, C1-C6-alkylsulphonyl- amino, C1-C6-alkylsulphonyl and C1-C6-alkylthio; The new compounds shall be used for the manufacture of medicaments, in particular medicaments for improving, perception, concentration, learning and/or memory in patients in need thereof.

  该发明涉及新型取代吡唑吡嘧啶化合物。从化学角度来看，这些化合物的特征由一般式（I）表示：其中R1为苯基或吡啶基，其中任一取代为1到4个，优选为1到3个取代基X；X独立地选自C2-C6-烷基或C1-C6-烷氧基，其中C2-C6-烷基和C1-C6-烷氧基至少经过二卤化至全卤化处理，最好具有2到6个卤素取代基，卤素原子选自氟、氯和溴，最好为氟；R2为苯基或杂环烷基，其中苯基取代为1到3个基团，杂环烷基可选择性地取代为1到3个基团，每种基团独立地选自C1-C6-烷基、C1-C6-烷氧基、羟基羰基、氰基、三氟甲基、氨基、硝基、羟基、C1-C6-烷基氨基、卤素、C6-C10-芳基羰胺基、C1-C6-烷基羰胺基、C1-C6-烷氨基羰基、C1-C6-烷氧羰基、C6-C10-芳基氨基羰基、杂环烷基氨基羰基、杂环烷基羰胺基、C1-C6-烷基磺酰氨基、C1-C6-烷基磺酰基和C1-C6-烷基硫基；这些新化合物可用于制备药物，特别是用于改善患者的感知、注意力、学习和/或记忆的药物。